Øystein Fodstad

Publications published since 1976 or in press by Øystein Fodstad

274 publications found

Publications in press

1. Bergman AM, Adema AD, Balzarini J, Bruheim S, Fichtner I, Noordhuis P, Fodstad O, Myhren F, Sandvold ML, Hendriks HR, Peters GJ
   Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
   Invest New Drugs (in press)
   PubMed 20066470

Publications 2010

1. Briggs JJ, Haugen MH, Johansen HT, Riker AI, Abrahamson M, Fodstad Ø, Maelandsmo GM, Solberg R (2010)
   Cystatin E/M suppresses legumain activity and invasion of human melanoma
   BMC Cancer, 10, 17
   PubMed 20074384
2. Bruland OS, Høifødt H, Hall KS, Smeland S, Fodstad O (2010)
   Bone Marrow Micrometastases Studied by an Immunomagnetic Isolation Procedure in Extremity Localized Non-metastatic Osteosarcoma Patients
   Cancer Treat Res, 152, 509-15
   PubMed 20213412
3. Davies ML, Parr C, Sanders AJ, Fodstad O, Jiang WG (2010)
   The transcript expression and protein distribution pattern in human colorectal carcinoma reveal a pivotal role of COM-1/p8 as a tumour suppressor
   Cancer Genomics Proteomics, 7 (2), 75-80
   PubMed 20335521
4. Mercapide J, Rappa G, Anzanello F, King J, Fodstad O, Lorico A (2010)
   Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma
   Int J Cancer, 126 (5), 1206-15
   PubMed 19653275
5. Metge BJ, Liu S, Riker AI, Fodstad O, Samant RS, Shevde LA (2010)
   Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1
   Oncology, 78 (1), 75-86
   PubMed 20215788
6. Prasmickaite L, Skrbo N, Høifødt HK, Suo Z, Engebråten O, Gullestad HP, Aamdal S, Fodstad Ø, Maelandsmo GM (2010)
   Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells
   Pigment Cell Melanoma Res, 23 (3), 449-51
   PubMed 20236249
7. Ren S, Liu S, Howell PM, Zhang G, Pannell L, Samant R, Shevde-Samant L, Tucker JA, Fodstad O, Riker AI (2010)
   Functional characterization of the progestagen-associated endometrial protein gene in human melanoma
   J Cell Mol Med, 14 (6B), 1432-42
   PubMed 19799645
8. Risberg K, Fodstad O, Andersson Y (2010)
   Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells
   J Immunother, 33 (3), 272-8
   PubMed 20445347
9. Wiiger MT, Gehrken HB, Fodstad O, Mælandsmo GM, Andersson Y (2010)
   A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
   Cancer Immunol Immunother, 59 (11), 1665-1674
   PubMed 20635083
10. Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, Xiong W, Li G, Lu J, Fodstad O, Riker AI, Tan M (2010)
    MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression
    J Biol Chem, 285 (28), 21496-507
    PubMed 20460378
11. Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, Fodstad O, Riker AI, Kamarajugadda S, Lu J, Owen LB, Ledoux SP, Tan M (2010)
    Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol
    Mol Cancer, 9, 33
    PubMed 20144215

Publications 2009

1. Andersson Y, Engebraaten O, Fodstad Ø (2009)
   Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo
   Br J Cancer, 101 (8), 1307-15
   PubMed 19773757
2. Bergamaschi A, Hjortland GO, Triulzi T, Sørlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O (2009)
   Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
   Mol Oncol, 3 (5-6), 469-82
   PubMed 19713161
3. Bratland A, Boender PJ, Høifødt HK, Østensen IH, Ruijtenbeek R, Wang MY, Berg JP, Lilleby W, Fodstad Ø, Ree AH (2009)
   Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling
   Clin Exp Metastasis, 26 (5), 485-96
   PubMed 19294521
4. Bruheim S, Xi Y, Ju J, Fodstad O (2009)
   Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide
   Clin Cancer Res, 15 (23), 7161-9
   PubMed 19920113
5. Chowdhury UR, Samant RS, Fodstad O, Shevde LA (2009)
   Emerging role of nuclear protein 1 (NUPR1) in cancer biology
   Cancer Metastasis Rev, 28 (1-2), 225-32
   PubMed 19153668
6. Eide N, Faye RS, Høifødt HK, Øvergaard R, Jebsen P, Kvalheim G, Fodstad Ø (2009)
   Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients
   Acta Ophthalmol, 87 (8), 830-6
   PubMed 19055657
7. Engebraaten O, Trikha M, Juell S, Garman-Vik S, Fodstad Ø (2009)
   Inhibition of in vive tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins
   Anticancer Res, 29 (1), 131-7
   PubMed 19331142
8. Howell PM, Liu S, Ren S, Behlen C, Fodstad O, Riker AI (2009)
   Epigenetics in human melanoma
   Cancer Control, 16 (3), 200-18
   PubMed 19556960
9. Liu S, Howell P, Ren S, Fodstad O, Riker AI (2009)
   The 14-3-3sigma gene promoter is methylated in both human melanocytes and melanoma
   BMC Cancer, 9, 162
   PubMed 19473536
10. Liu S, Howell P, Ren S, Fodstad O, Zhang G, Samant R, Shevde L, Xi Y, Pannell LK, Riker AI (2009)
    Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma
    Clin Exp Metastasis, 26 (7), 739-49
    PubMed 19488830
11. Lorico A, Mercapide J, Solodushko V, Alexeyev M, Fodstad O, Rappa G (2009)
    Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma (vol 15, pg 605, 2008)
    Cancer Gene Ther., 16 (6), 539
12. Risberg K, Fodstad Ø, Andersson Y (2009)
    The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro
    Int J Cancer, 125 (1), 23-33
    PubMed 19350633
13. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O, Ju J (2009)
    Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
    Oncogene, 28 (46), 4065-74
    PubMed 19734943
14. Zhao YH, Zhou M, Liu H, Ding Y, Khong HT, Yu D, Fodstad O, Tan M (2009)
    Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth
    Oncogene, 28 (42), 3689-701
    PubMed 19668225

Publications 2008

1. Brunsvig PF, Flatmark K, Aamdal S, Høifødt H, Le H, Jakobsen E, Sandstad B, Fodstad O (2008)
   Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients
   Lung Cancer, 61 (2), 170-6
   PubMed 18261824
2. Chen YW, Tekle C, Fodstad O (2008)
   The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion
   Curr Cancer Drug Targets, 8 (5), 404-13
   PubMed 18690846
3. Clark DW, Mitra A, Fillmore RA, Jiang WG, Samant RS, Fodstad O, Shevde LA (2008)
   NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress
   Curr Cancer Drug Targets, 8 (5), 421-30
   PubMed 18690848
4. Faye RS, Paus E, Maelandsmo GM, Berner A, Høifødt HK, Fodstad Ø, Aamdal S (2008)
   S100B in bone marrow aspirates in healthy individuals and malignant melanoma patients
   Melanoma Res, 18 (2), 134-40
   PubMed 18337650
5. Liu S, Ren S, Howell P, Fodstad O, Riker AI (2008)
   Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling
   Pigment Cell Melanoma Res, 21 (5), 545-58
   PubMed 18627528
6. Lorico A, Mercapide J, Solodushko V, Alexeyev M, Fodstad O, Rappa G (2008)
   Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma
   Cancer Gene Ther, 15 (9), 605-15
   PubMed 18421309
7. Nakajima G, Patino-Garcia A, Bruheim S, Xi Y, San Julian M, Lecanda F, Sierrasesumaga L, Müller C, Fodstad O, Ju J (2008)
   CDH11 expression is associated with survival in patients with osteosarcoma
   Cancer Genomics Proteomics, 5 (1), 37-42
   PubMed 18359978
8. Rappa G, Fodstad O, Lorico A (2008)
   The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma
   Stem Cells, 26 (12), 3008-17
   PubMed 18802032
9. Rappa G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, Fodstad O, Lorico A (2008)
   Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets
   Exp Cell Res, 314 (10), 2110-22
   PubMed 18423605
10. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J (2008)
    The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
    BMC Med Genomics, 1, 13
    PubMed 18442402
11. Xi Y, Riker A, Shevde-Samant L, Samant R, Morris C, Gavin E, Fodstad O, Ju J (2008)
    Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts
    Cancer Genomics Proteomics, 5 (1), 1-35
    PubMed 18359977

Publications 2007

1. Bauer NN, Chen YW, Samant RS, Shevde LA, Fodstad O (2007)
   Rac1 activity regulates proliferation of aggressive metastatic melanoma
   Exp Cell Res, 313 (18), 3832-9
   PubMed 17904119
2. Flatmark K, Reed W, Halvorsen T, Sørensen O, Wiig JN, Larsen SG, Fodstad Ø, Giercksky KE (2007)
   Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype
   BMC Cancer, 7, 116
   PubMed 17603904
3. Fodstad Ø (2007)
   [The 75th anniversary of the Radium Hospital]
   Tidsskr Nor Laegeforen, 127 (13), 1800-1
   PubMed 17599133
4. Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O (2007)
   Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines
   J Gene Med, 9 (6), 440-51
   PubMed 17410615
5. Rappa G, Anzanello F, Alexeyev M, Fodstad O, Lorico A (2007)
   Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease
   Eur J Haematol, 78 (5), 440-8
   PubMed 17331133
6. Thies A, Mauer S, Fodstad O, Schumacher U (2007)
   Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice
   Br J Cancer, 96 (4), 609-16
   PubMed 17262079
7. Tveito S, Maelandsmo GM, Hoifodt HK, Rasmussen H, Fodstad O (2007)
   Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value
   Clin Exp Metastasis, 24 (5), 317-27
   PubMed 17530423

Publications 2006

1. Andersson Y, Le H, Juell S, Fodstad Ø (2006)
   AMP-activated protein kinase protects against anti-epidermal growth factor receptor-Pseudomonas exotoxin A immunotoxin-induced MA11 breast cancer cell death
   Mol Cancer Ther, 5 (4), 1050-9
   PubMed 16648577
2. Flatmark K, Nome RV, Folkvord S, Bratland A, Rasmussen H, Ellefsen MS, Fodstad Ø, Ree AH (2006)
   Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
   Radiat Oncol, 1, 25
   PubMed 16887021
3. Jiang WG, Davies G, Kynaston H, Mason MD, Fodstad O (2006)
   Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer?
   Int J Mol Med, 18 (6), 1169-75
   PubMed 17089023
4. Jiang WG, Davies G, Martin TA, Kynaston H, Mason MD, Fodstad O (2006)
   Com-1/p8 acts as a putative tumour suppressor in prostate cancer
   Int J Mol Med, 18 (5), 981-6
   PubMed 17016631
5. Mbeunkui F, Fodstad O, Pannell LK (2006)
   Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS
   J Proteome Res, 5 (4), 899-906
   PubMed 16602697
6. Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y (2006)
   DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
   Anticancer Res, 26 (3A), 1909-16
   PubMed 16827124
7. Xi Y, Nakajima G, Hamil T, Fodstad O, Riker A, Ju J (2006)
   Association of insulin-like growth factor binding protein-3 expression with melanoma progression
   Mol Cancer Ther, 5 (12), 3078-84
   PubMed 17172410
8. Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J (2006)
   Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer
   Clin Cancer Res, 12 (7 Pt 1), 2014-24
   PubMed 16609010

Publications 2005

1. Bjørnland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O, Maelandsmo GM (2005)
   Matrix metalloproteinases participate in osteosarcoma invasion
   J Surg Res, 127 (2), 151-6
   PubMed 16083752
2. Bruland OS, Høifødt H, Saeter G, Smeland S, Fodstad O (2005)
   Hematogenous micrometastases in osteosarcoma patients
   Clin Cancer Res, 11 (13), 4666-73
   PubMed 16000559
3. Engesaeter BØ, Bonsted A, Berg K, Høgset A, Engebråten O, Fodstad Ø, Curiel DT, Maelandsmo GM (2005)
   PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles
   Cancer Gene Ther, 12 (5), 439-48
   PubMed 15678152
4. Jiang WG, Davies G, Fodstad O (2005)
   Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection
   Biochem Biophys Res Commun, 330 (1), 253-62
   PubMed 15781258
5. Jiang WG, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE, Fodstad O (2005)
   Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status
   Int J Cancer, 117 (5), 730-7
   PubMed 15957166
6. Lillehammer T, Tveito S, Engesaeter BO, Fodstad O, Maelandsmo GM, Engebraaten O (2005)
   Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers
   Cancer Gene Ther, 12 (11), 864-72
   PubMed 15891771
7. Lorico A, Bratbak D, Meyer J, Kunke D, Krauss S, Plott WE, Solodushko V, Baum C, Fodstad O, Rappa G (2005)
   Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells
   Hum Gene Ther, 16 (6), 711-24
   PubMed 15960602
8. Lund T, Stokke T, Olsen ØE, Fodstad Ø (2005)
   Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis
   Br J Cancer, 92 (9), 1773-81
   PubMed 15827557
9. Nome RV, Bratland A, Harman G, Fodstad O, Andersson Y, Ree AH (2005)
   Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death
   Mol Cancer Ther, 4 (8), 1231-8
   PubMed 16093439

Publications 2004

1. Andersen K, Nesland JM, Holm R, Flørenes VA, Fodstad Ø, Maelandsmo GM (2004)
   Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma
   Mod Pathol, 17 (8), 990-7
   PubMed 15133476
2. Andersson Y, Juell S, Fodstad Ø (2004)
   Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin
   Int J Cancer, 112 (3), 475-83
   PubMed 15382075
3. Bergman AM, Kuiper CM, Noordhuis P, Smid K, Voorn DA, Comijn EM, Myhren F, Sandvold ML, Hendriks HR, Fodstad O, Breistøl K, Peters GJ (2004)
   Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts
   Nucleosides Nucleotides Nucleic Acids, 23 (8-9), 1329-33
   PubMed 15571253
4. Bruheim S, Bruland OS, Breistol K, Maelandsmo GM, Fodstad O (2004)
   Human osteosarcoma xenografts and their sensitivity to chemotherapy
   Pathol Oncol Res, 10 (3), 133-41
   PubMed 15448748
5. Faye RS, Aamdal S, Høifødt HK, Jacobsen E, Holstad L, Skovlund E, Fodstad Ø (2004)
   Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients
   Clin Cancer Res, 10 (12 Pt 1), 4134-9
   PubMed 15217950
6. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad Ø (2004)
   Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice
   Eur J Cancer, 40 (10), 1593-8
   PubMed 15196545
7. Flatmark K, Maelandsmo GM, Mikalsen SO, Nustad K, Varaas T, Rasmussen H, Meling GI, Fodstad Ø, Paus E (2004)
   Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum
   Tumour Biol, 25 (1-2), 31-40
   PubMed 15192310
8. Hjortland GO, Garman-Vik SS, Juell S, Olsen OE, Hirschberg H, Fodstad O, Engebraaten O (2004)
   Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme
   J Neurosurg, 100 (2), 320-7
   PubMed 15086240
9. Hjortland GO, Lillehammer T, Somme S, Wang J, Halvorsen T, Juell S, Hirschberg H, Fodstad Ø, Engebraaten O (2004)
   Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells
   Exp Cell Res, 294 (1), 130-9
   PubMed 14980508
10. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE (2004)
    Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer
    Endocr Relat Cancer, 11 (4), 781-91
    PubMed 15613452
11. King JA, Ofori-Acquah SF, Stevens T, Al-Mehdi AB, Fodstad O, Jiang WG (2004)
    Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator
    Breast Cancer Res, 6 (5), R478-87
    PubMed 15318930
12. Pedersen KB, Andersen K, Fodstad Ø, Maelandsmo GM (2004)
    Sensitization of interferon-gamma induced apoptosis in human osteosarcoma cells by extracellular S100A4
    BMC Cancer, 4, 52
    PubMed 15318945
13. Rappa G, Kunke D, Holter J, Diep DB, Meyer J, Baum C, Fodstad O, Krauss S, Lorico A (2004)
    Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin
    Neuroscience, 124 (4), 823-30
    PubMed 15026123
14. Ree AH, Bratland A, Nome RV, Stokke T, Fodstad O, Andersson Y (2004)
    Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?
    Radiother Oncol, 72 (3), 305-10
    PubMed 15450729
15. Ree AH, Bratland A, Solberg Landsverk K, Fodstad O (2004)
    Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner
    Anticancer Res, 24 (2B), 555-62
    PubMed 15160994
16. Wang X, Wang M, Amarzguioui M, Liu F, Fodstad Ø, Prydz H (2004)
    Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice
    Int J Cancer, 112 (6), 994-1002
    PubMed 15386437

Publications 2003

1. Andersen K, Smith-Sørensen B, Pedersen KB, Hovig E, Myklebost O, Fodstad Ø, Maelandsmo GM (2003)
   Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest
   Br J Cancer, 88 (12), 1995-2001
   PubMed 12799648
2. Bjørnland K, Flatmark K, Mala T, Mathisen O, Bakka A, Aasen AO, Bergan A, Søreide O, Fodstad O (2003)
   Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer
   J Surg Oncol, 82 (4), 224-7
   PubMed 12672004
3. Bratland A, Ragnhildstveit E, Bjørnland K, Andersen K, Maelandsmo GM, Fodstad O, Saatcioglu F, Ree AH (2003)
   The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells
   Clin Exp Metastasis, 20 (6), 541-7
   PubMed 14598888
4. Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjørnland K, Fodstad Ø, Maelandsmo GM (2003)
   Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer
   J Pathol, 200 (5), 589-95
   PubMed 12898594
5. Hjortland GO, Bjørnland K, Pettersen S, Garman-Vik SS, Emilsen E, Nesland JM, Fodstad O, Engebraaten O (2003)
   Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1
   Clin Exp Metastasis, 20 (4), 301-9
   PubMed 12856717
6. Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA (2003)
   Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma
   Clin Cancer Res, 9 (9), 3383-8
   PubMed 12960126
7. Mathisen B, Lindstad RI, Hansen J, El-Gewely SA, Maelandsmo GM, Hovig E, Fodstad O, Loennechen T, Winberg JO (2003)
   S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells
   Clin Exp Metastasis, 20 (8), 701-11
   PubMed 14713104
8. Nygaard V, Løland A, Holden M, Langaas M, Rue H, Liu F, Myklebost O, Fodstad Ø, Hovig E, Smith-Sørensen B (2003)
   Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance
   BMC Genomics, 4 (1), 11
   PubMed 12659661
9. Rappa G, Gamcsik MP, Mitina RL, Baum C, Fodstad O, Lorico A (2003)
   Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy
   Eur J Cancer, 39 (1), 120-8
   PubMed 12504668
10. Ree AH, Bratland A, Nome RV, Stokke T, Fodstad Ø (2003)
    Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
    Oncogene, 22 (55), 8952-5
    PubMed 14654792

Publications 2002

1. Engebraaten O, Hjortland GO, Juell S, Hirschberg H, Fodstad O (2002)
   Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals
   Int J Cancer, 97 (6), 846-52
   PubMed 11857366
2. Flatmark K, Bjørnland K, Johannessen HO, Hegstad E, Rosales R, Hårklau L, Solhaug JH, Faye RS, Søreide O, Fodstad Ø, Study Group for Micrometastases in BM in Colorectal Cancer (2002)
   Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients
   Clin Cancer Res, 8 (2), 444-9
   PubMed 11839662
3. Henriksen G, Breistøl K, Bruland ØS, Fodstad Ø, Larsen RH (2002)
   Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model
   Cancer Res, 62 (11), 3120-5
   PubMed 12036923
4. Høgset A, Engesaeter BO, Prasmickaite L, Berg K, Fodstad O, Maelandsmo GM (2002)
   Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy
   Cancer Gene Ther, 9 (4), 365-71
   PubMed 11960287
5. Lorico A, Bertola A, Baum C, Fodstad O, Rappa G (2002)
   Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice
   Biochem Biophys Res Commun, 291 (3), 617-22
   PubMed 11855834
6. Lorico A, Nesland J, Emilsen E, Fodstad O, Rappa G (2002)
   Role of the multidrug resistance protein 1 gene in the carcinogenicity of aflatoxin B1: investigations using mrp1-null mice
   Toxicology, 171 (2-3), 201-5
   PubMed 11836025
7. Marth C, Kisic J, Kaern J, Tropé C, Fodstad Ø (2002)
   Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis
   Cancer, 94 (3), 707-12
   PubMed 11857303
8. Pedersen KB, Nesland JM, Fodstad Ø, Maelandsmo GM (2002)
   Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies
   Br J Cancer, 87 (11), 1281-6
   PubMed 12439718
9. Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
   Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
   Anticancer Res, 22 (4), 1949-57
   PubMed 12174869
10. Ree AH, Engebraaten O, Hovig E, Fodstad Ø (2002)
    Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: gene expression profiles in bone marrow target cells
    Int J Cancer, 97 (1), 28-33
    PubMed 11774240
11. Smith-Sørensen B, Lind GE, Skotheim RI, Fosså SD, Fodstad Ø, Stenwig AE, Jakobsen KS, Lothe RA (2002)
    Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer
    Oncogene, 21 (57), 8878-84
    PubMed 12483540

Publications 2001

1. Bjørnland K, Bratland A, Rugnes E, Pettersen S, Johansen HT, Aasen AO, Fodstad Ø, Ree AH, Maelandsmo GM (2001)
   Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells
   J Pediatr Surg, 36 (7), 1040-4
   PubMed 11431772
2. Fodstad O, Faye R, Høifødt HK, Skovlund E, Aamdal S (2001)
   Immunobead-based detection and characterization of circulating tumor cells in melanoma patients
   Recent Results Cancer Res, 158, 40-50
   PubMed 11092032
3. Forus A, D'Angelo A, Henriksen J, Merla G, Maelandsmo GM, Flørenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F, Müller C, Sanvito F, Kononen J, Nesland JM, Fodstad Ø, Reymond A, Kallioniemi OP, Arrigoni G, Ballabio A, Myklebost O, Zollo M (2001)
   Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity
   Oncogene, 20 (47), 6881-90
   PubMed 11687967
4. Hovig E, Maelandsmo G, Mellingsaeter T, Fodstad O, Mielewczyk SS, Wolfe J, Goodchild J (2001)
   Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA
   Antisense Nucleic Acid Drug Dev, 11 (2), 67-75
   PubMed 11334142
5. Ivanov VN, Fodstad O, Ronai Z (2001)
   Expression of ring finger-deleted TRAF2 sensitizes metastatic melanoma cells to apoptosis via up-regulation of p38, TNFalpha and suppression of NF-kappaB activities
   Oncogene, 20 (18), 2243-53
   PubMed 11402319
6. Rappa G, Lorico A, Hildinger M, Fodstad Ø, Baum C (2001)
   Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents
   Hum Gene Ther, 12 (14), 1785-96
   PubMed 11560771
7. Siewert C, Herber M, Hunzelmann N, Fodstad O, Miltenyi S, Assenmacher M, Schmitz J (2001)
   Rapid enrichment and detection of melanoma cells from peripheral blood mononuclear cells by a new assay combining immunomagnetic cell sorting and immunocytochemical staining
   Recent Results Cancer Res, 158, 51-60
   PubMed 11092033

Publications 2000

1. Bratland A, Risberg K, Maelandsmo GM, Gützkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, Ree AH (2000)
   Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells
   Cancer Res, 60 (19), 5578-83
   PubMed 11034106
2. Engebraaten O, Sivam G, Juell S, Fodstad O (2000)
   Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats
   Int J Cancer, 88 (6), 970-6
   PubMed 11093823
3. Rappa G, Shyam K, Lorico A, Fodstad O, Sartorelli AC (2000)
   Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16)
   Oncol Res, 12 (3), 113-9
   PubMed 11216669
4. Ree AH, Pacheco MM, Tvermyr M, Fodstad O, Brentani MM (2000)
   Expression of a novel factor, com1, in early tumor progression of breast cancer
   Clin Cancer Res, 6 (5), 1778-83
   PubMed 10815897
5. Selbo PK, Sivam G, Fodstad O, Sandvig K, Berg K (2000)
   Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin
   Int J Cancer, 87 (6), 853-9
   PubMed 10956397

Publications 1999

1. Berg K, Selbo PK, Prasmickaite L, Tjelle TE, Sandvig K, Moan J, Gaudernack G, Fodstad O, Kjølsrud S, Anholt H, Rodal GH, Rodal SK, Høgset A (1999)
   Photochemical internalization: a novel technology for delivery of macromolecules into cytosol
   Cancer Res, 59 (6), 1180-3
   PubMed 10096543
2. Bjørnland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O, Maelandsmo GM (1999)
   S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme
   Cancer Res, 59 (18), 4702-8
   PubMed 10493528
3. Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, Smith BM, Wunder E, Marolleau JP, Garcia J, Pantel K (1999)
   Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
   Cytotherapy, 1 (5), 377-88
   PubMed 20426539
4. Breistøl K, Balzarini J, Sandvold ML, Myhren F, Martinsen M, De Clercq E, Fodstad O (1999)
   Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models
   Cancer Res, 59 (12), 2944-9
   PubMed 10383159
5. Breistøl K, Hendriks HR, Fodstad O (1999)
   Superior therapeutic efficacy of N-L-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drug
   Eur J Cancer, 35 (7), 1143-9
   PubMed 10533461
6. Engebraaten O, Fodstad O (1999)
   Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats
   Int J Cancer, 82 (2), 219-25
   PubMed 10389756
7. Engebraaten O, Hjortland GO, Hirschberg H, Fodstad O (1999)
   Growth of precultured human glioma specimens in nude rat brain
   J Neurosurg, 90 (1), 125-32
   PubMed 10413165
8. Forus A, Høifødt HK, Overli GE, Myklebost O, Fodstad O (1999)
   Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates
   Mol Pathol, 52 (2), 68-74
   PubMed 10474684
9. Pantel K, Cote RJ, Fodstad O (1999)
   Detection and clinical importance of micrometastatic disease
   J Natl Cancer Inst, 91 (13), 1113-24
   PubMed 10393719
10. Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O (1999)
    Expression of a novel factor in human breast cancer cells with metastatic potential
    Cancer Res, 59 (18), 4675-80
    PubMed 10493524
11. Ruud P, Fodstad O, Hovig E (1999)
    Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells
    Int J Cancer, 80 (1), 119-25
    PubMed 9935241

Publications 1998

1. Andersen K, Maelandsmo GM, Hovig E, Fodstad O, Loennechen T, Winberg JO (1998)
   Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL
   Anticancer Res, 18 (5A), 3299-303
   PubMed 9858899
2. Bjørnland K, Lehne G, Johansen HT, Fodstad O, Rugstad HE, Aasen AO, Ree AH (1998)
   Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells
   Oncol Res, 10 (5), 255-62
   PubMed 9802060
3. Breistøl K, Hendriks HR, Berger DP, Langdon SP, Fiebig HH, Fodstad O (1998)
   The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts
   Eur J Cancer, 34 (10), 1602-6
   PubMed 9893636
4. Forus A, Berner JM, Meza-Zepeda LA, Saeter G, Mischke D, Fodstad O, Myklebost O (1998)
   Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas
   Br J Cancer, 78 (4), 495-503
   PubMed 9716033
5. Prasmickaite L, Hogset A, Maelandsmo G, Berg K, Goodchild J, Perkins T, Fodstad O, Hovig E (1998)
   Intracellular metabolism of a 2'-O-methyl-stabilized ribozyme after uptake by DOTAP transfection or asfree ribozyme. A study by capillary electrophoresis
   Nucleic Acids Res, 26 (18), 4241-8
   PubMed 9722645
6. Ree AH, Bjørnland K, Brünner N, Johansen HT, Pedersen KB, Aasen AO, Fodstad O (1998)
   Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells
   Clin Exp Metastasis, 16 (3), 205-15
   PubMed 9568638
7. Rye PD, Fodstad O, Emilsen E, Bryne M (1998)
   Invasion potential and N-acetylgalactosamine expression in a human melanoma model
   Int J Cancer, 75 (4), 609-14
   PubMed 9466664

Publications 1997

1. Berner JM, Meza-Zepeda LA, Kools PF, Forus A, Schoenmakers EF, Van de Ven WJ, Fodstad O, Myklebost O (1997)
   HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas
   Oncogene, 14 (24), 2935-41
   PubMed 9205100
2. de Graaf H, Maelandsmo GM, Ruud P, Forus A, Oyjord T, Fodstad O, Hovig E (1997)
   Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2
   Int J Cancer, 72 (1), 191-6
   PubMed 9212242
3. Geurts van Kessel A, dos Santos NR, Simons A, de Bruijn D, Forus A, Fodstad O, Myklebost O, Balemans M, Baats E, Olde Weghuis D, Suijkerbuijk RF, van den Berg E, Molenaar WM, de Leeuw B (1997)
   Molecular cytogenetics of bone and soft tissue tumors
   Cancer Genet Cytogenet, 95 (1), 67-73
   PubMed 9140455
4. Maelandsmo GM, Flørenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O (1997)
   Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma
   Int J Cancer, 74 (4), 464-9
   PubMed 9291441
5. Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O (1997)
   High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases
   Clin Cancer Res, 3 (9), 1623-8
   PubMed 9815852
6. Rye PD, Høifødt HK, Overli GE, Fodstad O (1997)
   Immunobead filtration: a novel approach for the isolation and propagation of tumor cells
   Am J Pathol, 150 (1), 99-106
   PubMed 9006327
7. Semb KA, Fodstad O, Klem B, Bibow K, Osmundsen K, Aamdal S (1997)
   Zilascorb(H-2), a new reversible protein synthesis inhibitor: Clinical study of an oral preparation
   Anti-Cancer Drugs, 8 (3), 296-303
8. Semb KA, Fodstad O, Klem B, Bibow K, Osmundsen K, Aamdal S (1997)
   Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparation
   Anticancer Drugs, 8 (3), 296-303
   PubMed 9095337
9. vanKessel AG, dosSantos NR, Simons A, deBruijn D, Forus A, Fodstad O, Myklebost O, Balemans M, Baats E, Weghuis DO, Suijkerbuijk RF, vandenBerg E, Molenaar WM, deLeeuw B (1997)
   Molecular cytogenetics of bone and soft tissue tumors
   Cancer Genet. Cytogenet., 95 (1), 67-73

Publications 1996

1. Berner JM, Forus A, Elkahloun A, Meltzer PS, Fodstad O, Myklebost O (1996)
   Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas
   Genes Chromosomes Cancer, 17 (4), 254-9
   PubMed 8946207
2. Bjørnland K, Buø L, Kjønniksen I, Larsen M, Fodstad O, Johansen HT, Aasen AO (1996)
   Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro
   Anticancer Res, 16 (4A), 1627-31
   PubMed 8712680
3. Fodstad O, Breistøl K, Pettit GR, Shoemaker RH, Boyd MR (1996)
   Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts
   J Exp Ther Oncol, 1 (2), 119-25
   PubMed 9414395
4. Hovig E, Fodstad O (1996)
   [Prostate-specific membrane antigen]
   Tidsskr Nor Laegeforen, 116 (3), 411-2
   PubMed 8638273
5. Kvalheim G, Wang MY, Pharo A, Holte H, Jacobsen E, Beiske K, Kvaløy S, Smeland E, Funderud S, Fodstad O (1996)
   Purging of tumor cells from leukapheresis products: experimental and clinical aspects
   J Hematother, 5 (4), 427-36
   PubMed 8877718
6. Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O (1996)
   Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas
   Br J Cancer, 73 (8), 909-16
   PubMed 8611425
7. Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Flørenes VA (1996)
   Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions
   Am J Pathol, 149 (6), 1813-22
   PubMed 8952518
8. Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Flørenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O (1996)
   Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme
   Cancer Res, 56 (23), 5490-8
   PubMed 8968106
9. Ree AH, Maelandsmo GM, Fodstad O (1996)
   Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression
   Clin Exp Metastasis, 14 (4), 381-8
   PubMed 8878412
10. Rye PD, Norum L, Olsen DR, Garman-Vik S, Kaul S, Fodstad O (1996)
    Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11
    Int J Cancer, 68 (5), 682-7
    PubMed 8938153

Publications 1995

1. Deggerdal AH, Pettersen F, Kvalheim G, Hornes E, Smeland E, Fodstad O, Hovig E (1995)
   Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach
   Lab Invest, 72 (4), 411-8
   PubMed 7723279
2. Flørenes VA, Holm R, Fodstad O (1995)
   Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome
   Melanoma Res, 5 (3), 183-7
   PubMed 7640520
3. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, Geurts van Kessel A (1995)
   Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas
   Genes Chromosomes Cancer, 14 (1), 15-21
   PubMed 8527379
4. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, van Kessel AG (1995)
   Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas
   Genes Chromosomes Cancer, 14 (1), 8-14
   PubMed 8527390
5. Helseth A, Haug E, Nesland JM, Siegal GP, Fodstad O, Bautch VL (1995)
   Endocrine and metabolic characteristics of polyoma large T transgenic mice that develop ACTH-producing pituitary tumors
   J Neurosurg, 82 (5), 879-85
   PubMed 7714615
6. Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fodstad O, Myklebost O (1995)
   Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1
   Br J Cancer, 72 (2), 393-8
   PubMed 7640224
7. MAELANDSMO GM, SKREDE M, FLORENES VA, KASHANISABET M, HOVIG E, GRIGORIAN MS, HOVIG T, MYKLEBOST O, LUKANIDIN E, SCANLON K, FODSTAD O (1995)
   REVERSAL OF THE IN-VIVO METASTATIC PHENOTYPE OF HUMAN OSTEOSARCOMA CELLS BY AN ANTI-CAPL (MTS-1) RIBOZYME (VOL 55, PG 77, 1995)
   Cancer Res., 55 (11), 2484
8. Rye PD, Bovin NV, Vlasova E, Hoifodt HK, Kierulf B, Trones GE, Fodstad O (1995)
   Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure.
   Biochem. Soc. Trans., 23 (4), S584
9. Rye PD, Bovin NV, Vlasova E, Høifødt HK, Kierulf B, Trones GE, Fodstad O (1995)
   Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure
   Biochem Soc Trans, 23 (4), 584S
   PubMed 8654769
10. Wang MY, Fodstad O, Ludwig WD, Bengtsson M, Totterman T, Funderub S, Martin H, Kvalheim G (1995)
    An Effective, Direct Immunomagnetic Procedure for Purging Acute Lymphoblastic Leukemia Cells from Human Bone Marrow
    Pathol Oncol Res, 1 (1), 32-37
    PubMed 11173565
11. Wen DY, Hall WA, Conrad J, Godal A, Flørenes VA, Fodstad O (1995)
    In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line
    Neurosurgery, 36 (6), 1158-63; discussion 1163-4
    PubMed 7643997
12. Winderen M, Kjønniksen I, Fodstad O (1995)
    Pronounced therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor model
    J Natl Cancer Inst, 87 (3), 221-2
    PubMed 7707409

Publications 1994

1. Bruland OS, Fodstad O, Aas M, Solheim OP, Høie J, Skretting A, Winderen M, Michaelsen T, Pihl A (1994)
   Immunoscintigraphy of bone sarcomas--results in 5 patients
   Eur J Cancer, 30A (10), 1484-9
   PubMed 7833107
2. Buø L, Bjørnland K, Karlsrud TS, Kvale D, Kjønniksen I, Fodstad O, Brandtzaeg P, Johansen HT, Aasen AO (1994)
   Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines
   Anticancer Res, 14 (6B), 2445-51
   PubMed 7872665
3. Flørenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O (1994)
   Expression of the neuroectodermal intermediate filament nestin in human melanomas
   Cancer Res, 54 (2), 354-6
   PubMed 8275467
4. Flørenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O (1994)
   MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status
   J Natl Cancer Inst, 86 (17), 1297-302
   PubMed 8064888
5. Flørenes VA, Oyjord T, Holm R, Skrede M, Børresen AL, Nesland JM, Fodstad O (1994)
   TP53 allele loss, mutations and expression in malignant melanoma
   Br J Cancer, 69 (2), 253-9
   PubMed 7905277
6. Fodstad O, Kjønniksen I (1994)
   Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis
   J Cell Biochem, 56 (1), 23-8
   PubMed 7806588
7. Forus A, Flørenes VA, Maelandsmo GM, Fodstad O, Myklebost O (1994)
   The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas
   Cancer Genet Cytogenet, 78 (2), 165-71
   PubMed 7828148
8. Hall WA, Myklebust A, Godal A, Nesland JM, Fodstad O (1994)
   In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma
   Neurosurgery, 34 (4), 649-55; discussion 655-6
   PubMed 8008162
9. Kashani-Sabet M, Funato T, Florenes VA, Fodstad O, Scanlon KJ (1994)
   Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme
   Cancer Res, 54 (4), 900-2
   PubMed 8313379
10. Kjønniksen I, Rye PD, Fodstad O (1994)
    Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice
    Br J Cancer, 69 (6), 1021-4
    PubMed 8198963
11. Kjønniksen I, Winderen M, Bruland O, Fodstad O (1994)
    Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats
    Cancer Res, 54 (7), 1715-9
    PubMed 8137286
12. Kvalheim G, Jakobsen E, Holte H, Beiske K, Langholm R, Høiby A, Wang MY, Funderund S, Fodstad O, Smeland E (1994)
    Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads
    Prog Clin Biol Res, 389, 133-8
    PubMed 7700895
13. Langdon SP, Hendriks HR, Braakhuis BJ, Pratesi G, Berger DP, Fodstad O, Fiebig HH, Boven E (1994)
    Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study
    Ann Oncol, 5 (5), 415-22
    PubMed 8075048
14. Myklebust AT, Godal A, Fodstad O (1994)
    Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer
    Cancer Res, 54 (8), 2146-50
    PubMed 8174121
15. Myklebust AT, Godal A, Juell S, Pharo A, Fodstad O (1994)
    Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow
    Cancer Res, 54 (1), 209-14
    PubMed 7505198
16. Myklebust AT, Helseth A, Breistøl K, Hall WA, Fodstad O (1994)
    Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs
    J Neurooncol, 21 (3), 215-24
    PubMed 7699416
17. Wang MY, Fodstad O, Funderud S, Bengtsson M, Totterman T, Ludwig WD, Martin H, Kvalheim G (1994)
    A direct and effective immunomagnetic method for bone marrow purging in non-T ALL malignancies. The use of an anti-HLA-DR antibody gives sustained engraftment
    Prog Clin Biol Res, 389, 119-24
    PubMed 7700893

Publications 1993

1. ANDREASSEN A, BORRESEN AL, OYJORD T, SOLHEIM OP, FLORENES VA, BRULAND O, MYKLEBOST O, HOIE J, FODSTAD O (1993)
   CHROMOSOME-17P ABERRATIONS AND P53 EXPRESSION IN HUMAN SARCOMAS
   FRONTIERS OF OSTEOSARCOMA RESEARCH - INTERDISCIPLINARY SURVEY OF CLINICAL AND RESEARCH ADVANCES , 419-422
2. FODSTAD O (1993)
   METASTATIC ABILITY OF CANCER-CELLS - PHENOTYPIC AND GENOTYPIC CHARACTERISTICS AND ROLE OF THE MICROENVIRONMENT
   NEW FRONTIERS IN CANCER CAUSATION, 349-358
3. Forus A, Flørenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Myklebost O (1993)
   Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2
   Cell Growth Differ, 4 (12), 1065-70
   PubMed 8117620
4. Helseth A, Bautch VL, Haug E, Holm R, Nesland JM, Fodstad O (1993)
   [Transgenic mice as animal model of Cushing's syndrome]
   Tidsskr Nor Laegeforen, 113 (2), 206-10
   PubMed 8381565
5. Myklebust AT, Godal A, Pharo A, Juell S, Fodstad O (1993)
   Eradication of small cell lung cancer cells from human bone marrow with immunotoxins
   Cancer Res, 53 (16), 3784-8
   PubMed 8393381
6. Myklebust AT, Pharo A, Fodstad O (1993)
   Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads
   Br J Cancer, 67 (6), 1331-6
   PubMed 8390285
7. Schmid U, Bailly M, Fodstad O, Bihl H, Matzku S (1993)
   Monoclonal antibody accumulation in experimental and spontaneous lung metastases of human malignant melanoma in rodents
   J Cancer Res Clin Oncol, 119 (6), 342-5
   PubMed 8449971
8. Wen DY, Hall WA, Fodstad O (1993)
   Rapid detection of transferrin receptor expression on glioma cell lines by using magnetic microspheres
   Neurosurgery, 33 (5), 878-81
   PubMed 8264887

Publications 1992

1. Beiske K, Myklebust AT, Aamdal S, Langholm R, Jakobsen E, Fodstad O (1992)
   Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods
   Am J Pathol, 141 (3), 531-8
   PubMed 1381558
2. Boven E, Winograd B, Berger DP, Dumont MP, Braakhuis BJ, Fodstad O, Langdon S, Fiebig HH (1992)
   Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study
   Cancer Res, 52 (21), 5940-7
   PubMed 1394220
3. Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O (1992)
   Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression
   Cancer Res, 52 (21), 6088-91
   PubMed 1356624
4. FODSTAD O (1992)
   PRECLINICAL ANTICANCER DRUG-EVALUATION IN HUMAN TUMOR XENOGRAFTS
   CONTR ONCOL, 42, 352-361
5. Godal A, Kumle B, Pihl A, Juell S, Fodstad O (1992)
   Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations
   Int J Cancer, 52 (4), 631-5
   PubMed 1399146
6. GRZELAK I, OLSZEWSKI WL, ENGESET A, FODSTAD O (1992)
   THE INFLUENCE OF HUMAN SKIN LYMPH ON PROLIFERATION OF TUMOR-CELLS
   INT CONGR SER, 994, 365-367
7. Hall WA, Fodstad O (1992)
   Immunotoxins and central nervous system neoplasia
   J Neurosurg, 76 (1), 1-12
   PubMed 1727147
8. Hall WA, Godal A, Juell S, Fodstad O (1992)
   In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme
   J Neurosurg, 76 (5), 838-44
   PubMed 1314294
9. Hendriks HR, Langdon S, Berger DP, Breistøl K, Fiebig HH, Fodstad O, Schwartsmann G (1992)
   Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts
   Eur J Cancer, 28A (4-5), 767-73
   PubMed 1524896
10. Hendriks HR, Plowman J, Berger DP, Paull KD, Fiebig HH, Fodstad O, Dreef-van der Meulen HC, Henrar RE, Pinedo HM, Schwartsmann G (1992)
    Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent
    Ann Oncol, 3 (9), 755-63
    PubMed 1450065
11. Kjønniksen I, Breistøl K, Fodstad O (1992)
    Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin
    Cancer Res, 52 (5), 1347-51
    PubMed 1737396
12. STURTZ G, APPERE G, BREISTOL K, FODSTAD O, SCHWARTSMANN G, HENDRIKS HR (1992)
    A STUDY OF THE DELIVERY-TARGETING CONCEPT APPLIED TO ANTINEOPLASTIC DRUGS ACTIVE ON HUMAN OSTEOSARCOMA .1. SYNTHESIS AND BIOLOGICAL-ACTIVITY IN NUDE-MICE CARRYING HUMAN OSTEOSARCOMA XENOGRAFTS OF GEM-BISPHOSPHONIC METHOTREXATE ANALOGS
    Eur. J. Med. Chem., 27 (8), 825-833
13. Wang MY, Kvalheim G, Kvaløy S, Beiske K, Jakobsen E, Wijdenes J, Pihl A, Fodstad O (1992)
    An effective immunomagnetic method for bone marrow purging in T cell malignancies
    Bone Marrow Transplant, 9 (5), 319-23
    PubMed 1617315

Publications 1991

1. Fodstad O (1991)
   Tumorigenicity and dissemination of human tumors in congenitally immune-deficient mice
   J Natl Cancer Inst, 83 (19), 1419-20
   PubMed 1920486
2. Hovig E, Lothe R, Farrants G, Brøgger A, Fodstad O, Børresen AL (1991)
   Chromosome 13 alterations in osteosarcoma cell lines derived from a patient with previous retinoblastoma
   Cancer Genet Cytogenet, 57 (1), 31-40
   PubMed 1684533
3. Kjønniksen I, Høifødt HK, Pihl A, Fodstad O (1991)
   Different metastasis patterns of a human melanoma cell line in nude mice and rats: influence of microenvironment
   J Natl Cancer Inst, 83 (14), 1020-4
   PubMed 2072409
4. MYKLEBUST AT, BEISKE K, PHARO A, DAVIES CD, AAMDAL S, FODSTAD O (1991)
   SELECTION OF ANTI-SCLC ANTIBODIES FOR DIAGNOSIS OF BONE-MARROW METASTASIS
   Br. J. Cancer, 63 Suppl 14, 49-53
5. Myklebust AT, Beiske K, Pharo A, Davies CD, Aamdal S, Fodstad O (1991)
   Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis
   Br J Cancer Suppl, 14, 49-53
   PubMed 1645572
6. Shoemaker RH, Dykes DJ, Plowman J, Harrison SD, Griswold DP, Abbott BJ, Mayo JG, Fodstad O, Boyd MR (1991)
   Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma
   Cancer Res, 51 (11), 2837-41
   PubMed 2032224
7. Storeng RT, Kjønniksen I, Pihl A, Haug E, Fodstad O (1991)
   Athymic rats in preclinical immunodiagnostic studies
   Anticancer Res, 11 (2), 649-55
   PubMed 2064318

Publications 1990

1. FODSTAD O, KJONNIKSEN I (1990)
   EXPERIMENTAL BONE AND BONE-MARROW METASTASIS IN LABORATORY-ANIMALS - RESPONSE
   J. Natl. Cancer Inst., 82 (12), 1070
2. Kjønniksen I, Nesland JM, Pihl A, Fodstad O (1990)
   Nude rat model for studying metastasis of human tumor cells to bone and bone marrow
   J Natl Cancer Inst, 82 (5), 408-12
   PubMed 2304088

Publications 1989

1. Kjønniksen I, Storeng R, Pihl A, McLemore TL, Fodstad O (1989)
   A human tumor lung metastasis model in athymic nude rats
   Cancer Res, 49 (18), 5148-52
   PubMed 2766284
2. Kvalheim G, Fjeld JG, Pihl A, Funderud S, Ugelstad J, Fodstad O, Nustad K (1989)
   Immunomagnetic removal of B-lymphoma cells using a novel mono-sized magnetizable polymer bead, M-280, in conjunction with primary IgM and IgG antibodies
   Bone Marrow Transplant, 4 (5), 567-74
   PubMed 2790334
3. Shew JY, Ling N, Yang XM, Fodstad O, Lee WH (1989)
   Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas
   Oncogene Res, 4 (3), 205-14
   PubMed 2740144

Publications 1988

1. Boven E, Winograd B, Fodstad O, Lobbezoo MW, Pinedo HM (1988)
   Preclinical phase II studies in human tumor lines: a European multicenter study
   Eur J Cancer Clin Oncol, 24 (3), 567-73
   PubMed 3383962
2. Bruland OS, Fodstad O, Stenwig AE, Pihl A (1988)
   Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen
   Cancer Res, 48 (18), 5302-9
   PubMed 2457439
3. Fodstad O, Kjønniksen I, Aamdal S, Nesland JM, Boyd MR, Pihl A (1988)
   Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells
   Cancer Res, 48 (15), 4382-8
   PubMed 3390834
4. Fodstad O, Kvalheim G, Pihl A, Godal A, Funderud S (1988)
   New indirect approach to the therapeutic use of immunotoxins
   J Natl Cancer Inst, 80 (6), 439-43
   PubMed 3259265
5. Fodstad O, Aamdal S, McMenamin M, Nesland JM, Pihl A (1988)
   A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX
   Int J Cancer, 41 (3), 442-9
   PubMed 3346110
6. Godal A, Fodstad O, Pihl A (1988)
   Kinetics of uptake and degradation of an abrin immunotoxin by melanoma cells and studies of the rates of cellular intoxication
   Int J Cancer, 42 (3), 400-4
   PubMed 3262091
7. KVALHEIM G, FODSTAD O, FUNDERUD S, KIESEL S, DORKEN B, NUSTAD K, PIHL A (1988)
   IMMUNOMAGNETIC PURGING OF BETA-LYMPHOMA CELLS FROM BONE-MARROW
   Bone Marrow Transplant., 3 Suppl 1, 97
8. Kvalheim G, Funderud S, Kvaløy S, Gaudernack G, Beiske K, Jakobsen E, Jacobsen AB, Pihl A, Fodstad O (1988)
   Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation
   J Natl Cancer Inst, 80 (16), 1322-5
   PubMed 3050139
9. Kvalheim G, Sørensen O, Fodstad O, Funderud S, Kiesel S, Dörken B, Nustad K, Jakobsen E, Ugelstad J, Pihl A (1988)
   Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use
   Bone Marrow Transplant, 3 (1), 31-41
   PubMed 3048468
10. Aamdal S, Fodstad O, Pihl A (1988)
    Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors
    Cancer Chemother Pharmacol, 21 (2), 129-33
    PubMed 3349560

Publications 1987

1. Bruland O, Fodstad O, Skretting A, Pihl A (1987)
   Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts
   Br J Cancer, 56 (1), 21-5
   PubMed 3476143
2. Fine DL, Shoemaker R, Gazdar A, Mayo JG, Fodstad O, Boyd MR, Abbott BJ, Donovan PA (1987)
   Metastasis models for human tumors in athymic mice: useful models for drug development
   Cancer Detect Prev Suppl, 1, 291-9
   PubMed 3480056
3. Godal A, Fodstad O, Pihl A (1987)
   Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines
   Cancer Res, 47 (23), 6243-7
   PubMed 2445469
4. Gundersen S, Aamdal S, Fodstad O (1987)
   Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease
   Br J Cancer, 55 (4), 433-5
   PubMed 3580266
5. Hovig E, Winberg JO, Fodstad O, Brøgger A, Gedde-Dahl T (1987)
   Chromosome 13 instability and esterase D expression in an osteosarcoma cell line
   Cancer Genet Cytogenet, 24 (2), 327-34
   PubMed 2878716
6. Kvalheim G, Fodstad O, Pihl A, Nustad K, Pharo A, Ugelstad J, Funderud S (1987)
   Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies
   Cancer Res, 47 (3), 846-51
   PubMed 3492268
7. Aamdal S, Fodstad O, Pihl A (1987)
   Some procedures to reduce cis-platinum toxicity reduce antitumour activity
   Cancer Treat Rev, 14 (3-4), 389-95
   PubMed 3326670

Publications 1986

1. Bruland O, Fodstad O, Funderud S, Pihl A (1986)
   New monoclonal antibodies specific for human sarcomas
   Int J Cancer, 38 (1), 27-31
   PubMed 3522438
2. Fodstad O, Brøgger A, Bruland O, Solheim OP, Nesland JM, Pihl A (1986)
   Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma
   Int J Cancer, 38 (1), 33-40
   PubMed 3459716
3. Godal A, Bruland O, Haug E, Aas M, Fodstad O (1986)
   Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells
   Br J Cancer, 53 (6), 839-41
   PubMed 3718838
4. Godal A, Fodstad O, Morgan AC, Pihl A (1986)
   Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins
   J Natl Cancer Inst, 77 (6), 1247-53
   PubMed 3491924
5. Aamdal S, Fodstad O, Kaalhus O, Pihl A (1986)
   Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors
   Int J Cancer, 37 (4), 579-87
   PubMed 3957463

Publications 1985

1. Bruland O, Fodstad O, Pihl A (1985)
   The use of multicellular spheroids in establishing human sarcoma cell lines in vitro
   Int J Cancer, 35 (6), 793-8
   PubMed 2409034
2. Fodstad O, Aamdal S, Pihl A, Boyd MR (1985)
   Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas
   Cancer Res, 45 (4), 1778-86
   PubMed 3978640
3. Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brøgger A, Gedde-Dahl T, Cavenee WK (1985)
   Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition
   Proc Natl Acad Sci U S A, 82 (18), 6216-20
   PubMed 2994066
4. Hwang KM, Fodstad O, Oldham RK, Morgan AC (1985)
   Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice
   Cancer Res, 45 (9), 4150-5
   PubMed 4028007
5. Kvalheim G, Gundersen S, Hager B, Fodstad O (1985)
   Intra-arterial infusion of mitomycin C in treatment of breast cancer: occurrence of skin necrosis in irradiated patients
   Radiother Oncol, 4 (2), 127-32
   PubMed 3934716
6. Aamdal S, Fodstad O, Nesland JM, Pihl A (1985)
   Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice
   Br J Cancer, 51 (3), 347-56
   PubMed 3970811
7. AAMDAL S, FODSTAD O, PIHL A (1985)
   THE 6-DAY SUBRENAL CAPSULE ASSAY (SRCA) FOR TESTING THE RESPONSE OF HUMAN-TUMORS TO ANTICANCER AGENTS - VALIDITY AND USEFULNESS IN CANCER-RESEARCH AND TREATMENT
   Ann. Chir. Gynaecol., 74 Suppl 199, 51-59
8. Aamdal S, Fodstad O, Pihl A (1985)
   Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents
   Anticancer Res, 5 (4), 329-37
   PubMed 4037730
9. Aamdal S, Fodstad O, Pihl A (1985)
   The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatment
   Ann Chir Gynaecol Suppl, 199, 51-9
   PubMed 3864392

Publications 1984

1. Fodstad O, Hansen CT, Cannon GB, Boyd MR (1984)
   Immune characteristics of the beige-nude mouse. A model for studying immune surveillance
   Scand J Immunol, 20 (3), 267-72
   PubMed 6494809
2. Fodstad O, Hansen CT, Cannon GB, Statham CN, Lichtenstein GR, Boyd MR (1984)
   Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects
   Cancer Res, 44 (10), 4403-8
   PubMed 6467201
3. Fodstad O, Kvalheim G, Godal A, Lotsberg J, Aamdal S, Høst H, Pihl A (1984)
   Phase I study of the plant protein ricin
   Cancer Res, 44 (2), 862-5
   PubMed 6692385
4. Godal A, Fodstad O, Ingebrigtsen K, Pihl A (1984)
   Pharmacological studies of ricin in mice and humans
   Cancer Chemother Pharmacol, 13 (3), 157-63
   PubMed 6488437
5. Lindmo T, Davies C, Fodstad O, Morgan AC (1984)
   Stable quantitative differences of antigen expression in human melanoma cells isolated by flow cytometric cell sorting
   Int J Cancer, 34 (4), 507-12
   PubMed 6386700
6. Lindmo T, Davies C, Rofstad EK, Fodstad O, Sundan A (1984)
   Antigen expression in human melanoma cells in relation to growth conditions and cell-cycle distribution
   Int J Cancer, 33 (2), 167-71
   PubMed 6693198
7. Nesland JM, Kjellevold K, Finseth I, Fodstad O (1984)
   Spherical bodies
   Ultrastruct Pathol, 7 (1), 73-8
   PubMed 6097001
8. Aamdal S, Fodstad O, Kaalhus O, Pihl A (1984)
   Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle
   J Natl Cancer Inst, 73 (3), 743-52
   PubMed 6590919
9. Aamdal S, Fodstad O, Pihl A (1984)
   Human tumor xenografts transplanted under the renal capsule of conventional mice. Growth rates and host immune response
   Int J Cancer, 34 (5), 725-30
   PubMed 6500747

Publications 1983

1. Fodstad O, Rofstad EK, Tveit KM, Pihl A (1983)
   Spontaneous alteration in growth rates of two human melanoma xenografts. Concurrent changes in chemosensitivity
   Eur J Cancer Clin Oncol, 19 (8), 1175-8
   PubMed 6684563
2. Godal A, Fodstad O, Pihl A (1983)
   Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice
   Int J Cancer, 32 (4), 515-21
   PubMed 6618711

Publications 1982

1. Fodstad O, Pihl A (1982)
   Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia
   Cancer Res, 42 (6), 2152-8
   PubMed 7200398
2. Rofstad EK, Fodstad O, Lindmo T (1982)
   Growth characteristics of human melanoma xenografts
   Cell Tissue Kinet, 15 (5), 545-54
   PubMed 7127402
3. Tveit KM, Fodstad O, Lotsberg J, Vaage S, Pihl A (1982)
   Colony growth and chemosensitivity in vitro of human melanoma biopsies. Relationship to clinical parameters
   Int J Cancer, 29 (5), 533-8
   PubMed 7095899

Publications 1981

1. Tveit KM, Endresen L, Rugstad HE, Fodstad O, Pihl A (1981)
   Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas
   Br J Cancer, 44 (4), 539-44
   PubMed 7295510
2. Tveit KM, Fodstad O, Pihl A (1981)
   The usefulness of human tumor cell lines in the study of chemosensitivity. A study of malignant melanomas
   Int J Cancer, 28 (4), 403-8
   PubMed 7309286
3. Tveit KM, Fodstad O, Pihl A (1981)
   Cultivation of human melanomas in soft agar. Factors influencing plating efficiency and chemosensitivity
   Int J Cancer, 28 (3), 329-34
   PubMed 7319675

Publications 1980

1. Fodstad O, Pihl A (1980)
   Synergistic effect of adriamycin and ricin on L1210 leukemic cells in mice
   Cancer Res, 40 (10), 3735-9
   PubMed 7438056
2. Fodstad O, Pihl A (1980)
   Doxorubicin and ricin, a strongly synergistic combination in mouse leukemia
   Cancer Treat Rep, 64 (12), 1375-8
   PubMed 7471125
3. Fodstad O, Aass N, Pihl A (1980)
   Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice
   Int J Cancer, 25 (4), 453-8
   PubMed 7372371
4. Fodstad O, Aass N, Pihl A (1980)
   An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs
   Br J Cancer, 41 (5), 829-31
   PubMed 7426308
5. Fodstad O, Aass N, Pihl A (1980)
   Assessment of tumour growth and of response to chemotherapy of human melanomas in athymic, nude mice
   Br J Cancer Suppl, 4, 146-9
   PubMed 6932918
6. FODSTAD O, AASS N, PIHL A (1980)
   ASSESSMENT OF TUMOR-GROWTH AND OF RESPONSE TO CHEMOTHERAPY OF HUMAN MELANOMAS IN ATHYMIC, NUDE-MICE
   Br. J. Cancer, 41 Suppl 4, 146-149
7. Tveit KM, Fodstad O, Brøgger A, Olsnes S (1980)
   Human embryonal carcinoma grown in athymic mice and in vitro
   Cancer Res, 40 (3), 949-53
   PubMed 7471109
8. Tveit KM, Fodstad O, Johannessen JV, Olsnes S (1980)
   A human melanoma cell line established from xenograft in athymic mice
   Br J Cancer, 41 (5), 724-33
   PubMed 7426299
9. Tveit KM, Fodstad O, Olsnes S, Pihl A (1980)
   In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity
   Int J Cancer, 26 (6), 717-22
   PubMed 7216540

Publications 1979

1. Fodstad O (1979)
   Human gastrointestinal cancer grown in nude mice used to test new chemotherapeutic agents
   Front Gastrointest Res, 5, 71-80
   PubMed 91567
2. Fodstad O, Johannessen JV, Schjerven L, Pihl A (1979)
   Toxicity of abrin and ricin in mice and dogs
   J Toxicol Environ Health, 5 (6), 1073-84
   PubMed 529341
3. Gundersen S, Fodstad O (1979)
   Treatment of micrometastases from Lewis lung carcinoma with abrin and cyclophosphamide, given singly and in combination
   Int J Cancer, 23 (4), 530-5
   PubMed 437927

Publications 1978

1. Fodstad O, Pihl A (1978)
   Effect of ricin and abrin on survival of L1210 leukemic mice and on leukemic and normal bone-marrow cells
   Int J Cancer, 22 (5), 558-63
   PubMed 721316

Publications 1977

1. Fodstad O, Olsnes S (1977)
   Studies on the accessability of ribosomes to inactivation by the toxic lectins abrin and ricin
   Eur J Biochem, 74 (2), 209-15
   PubMed 856578
2. FODSTAD O, OLSNES S (1977)
   STUDIES ON ACCESSIBILITY OF RIBOSOMES TO INACTIVATION BY TOXIC LECTINS ABRIN AND RICIN
   Eur. J. Biochem., 74 (2), 209-215
3. Fodstad O, Olsnes S, Pihl A (1977)
   Inhibitory effect of abrin and ricin on the growth of transplantable murine tumors and of abrin on human cancers in nude mice
   Cancer Res, 37 (12), 4559-67
   PubMed 922739

Publications 1976

1. Fodstad O, Olsnes S, Pihl A (1976)
   Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice
   Br J Cancer, 34 (4), 418-25
   PubMed 974006